number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide New weight-loss drugs set to shake up pharma in 2026. Plus, semaglutide's patent expiry across major emerging markets, including India, Brazil and China, is expected to open the field to generic manufacturers Novo said its research shows

Here, the food and beverage industry is prepared to capitalize

Preparation for experimental use involves precise aliquoting and may require dilution or formulation adjustments depending on the study design

Can I switch from another provider to Brightmeds

Intense training blocks, illness recovery, or detoxification protocols

How does Ipamorelin differ from Sermorelin and Tesamorelin

FDA Commissioner Marty Makary stated that the agency was paying close attention to misleading claims "across all media platforms." For consumers, the most important compliance signal to look for in any compounded GLP-1 program is whether the company accurately describes what its medications are and are not